Delivery Order SPE2DB24D8001-SPE2DB25FLABN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,577.20 to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota, for the supply of Concerta ER 54 mg tablets (100 count). This delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, operates under a firm fixed-price contract type with no set-aside designation. The award falls under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $13,879.12 firm fixed-price delivery order is for the supply of 100 units of CONCERTA ER 18 MG TABLET, a prescription medication. The contract has an ultimate completion date of March 11, 2025. Dakota Drug, Inc. is an established federal contractor, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Concerta ER 36 mg tablets. The contract, valued at $7,494.21, is a firm fixed-price delivery order with an ultimate completion date of August 16, 2024. Dakota Drug, Inc. also holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999.00. This single-award IDC, part of the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $6,060.46, is for the delivery of Concerta ER 27 mg tablets in quantities of 100. The contract has an ultimate completion date of January 3, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense, and holds a...
- Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, has been awarded a firm fixed price delivery order totaling $4,087.36 against its blanket purchase agreement with the Defense Logistics Agency Troop Support Medical. Under this contract, Dakota Drug will provide 100 tablets of CONCERTA ER 54 MG to the agency's location in Anoka, Minnesota by November 24, 2023. As the prime contractor on this delivery order issued without a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,924.06 firm fixed-price delivery order is for the supply of 4565891400 CONCERTA ER 18 MG TABLET 100S. The contract, which does not have a set-aside designation, has an ultimate completion date of September 23, 2024. Dakota Drug, Inc. also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,563,197,921 units of Concerta ER 36 mg tablets. The contract, valued at $35,291.38, has an ultimate completion date of December 29, 2023. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and healthcare equipment to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Concerta ER 54 mg tablets. The contract, valued at $3,485.12, has a firm fixed-price delivery order type and an ultimate completion date of October 17, 2024. This award is not associated with any set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,172.38 firm fixed price delivery order is for the supply of CONCERTA ER 36 MG TABLET 100S. The contract has a performance period through November 19, 2024 and is not designated as a set-aside. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to...
- This federal contract award, identified as SPE2DX15D8003|SPE2DX24F7B3Y, was granted to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, valued at $17,482.96, is for the delivery of Concerta ER 18 mg tablets in 100-count bottles. This is a firm fixed-price delivery order contract with an ultimate completion date of October 12, 2023. Dakota Drug, Inc. is a key supplier for the DLA, holding a...
- SPE2DB24D8001Indefinite Delivery Contract
- SPE2DB24D8001-SPE2DB25FLABNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,419.38 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Concerta ER 18 mg tablets (100-count). The contract is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and represents performance at the contractor's Anoka facility. This award was not designated as a set-aside contract and was issued under Dakota Drug's existing Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, which is valued at $999.99 million through December 31, 2025. Dakota Drug, Inc. serves as a critical pharmaceutical supplier to the Defense Logistics Agency and U.S. Armed Forces medical operations, specializing in delivering medications and medical supplies to military healthcare facilities. The company's established track record includes supplying diverse pharmaceutical products ranging from diabetes management and respiratory medications to pain management drugs and vaccines. Under the parent ECAT Generation V Program, which originated from solicitation SPE2DH-21-R-0002 seeking commercial medical equipment, supplies, and consumables, Dakota Drug efficiently delivers essential medical items to defense healthcare facilities as part of the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 7/24/25 |